Cue Health is a healthcare technology company focused on developing and manufacturing professional and consumer medical diagnostic products that can be used in clinical or at-home settings.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
06/10/2020 | Series C-2 | $5.57MM | $xx.xx | $455.86MM | Acme Capital, Decheng Capital, Foresite Capital, Johnson & Johnson Innovation, Madrone Capital Partners | |
Price per Share
$xx.xx
Shares Outstanding
1,690,380
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Acme Capital, Decheng Capital, Foresite Capital, Johnson & Johnson Innovation, Madrone Capital Partners
|
||||||
06/10/2020 | Series C-1 | $100MM | $xx.xx | $455.86MM | Acme Capital, Decheng Capital, Foresite Capital, Johnson & Johnson Innovation, Madrone Capital Partners | |
Price per Share
$xx.xx
Shares Outstanding
27,308,229
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Acme Capital, Decheng Capital, Foresite Capital, Johnson & Johnson Innovation, Madrone Capital Partners
|
||||||
07/10/2018 | Series B | $66.29MM | $xx.xx | $116.64MM | Babel Ventures, Cove Investments, Dentsu Ventures, Jjdc Inc, Johnson & Johnson Innovation, Principles Of Tarsadia Investments, Pritzker Group Venture Capital, Rohan Oza, Section 32, Sherpa Ventures, Synergy Ventures, Troy Capital | |
Price per Share
$xx.xx
Shares Outstanding
46,208,084
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Babel Ventures, Cove Investments, Dentsu Ventures, Jjdc Inc, Johnson & Johnson Innovation, Principles Of Tarsadia Investments, Pritzker Group Venture Capital, Rohan Oza, Section 32, Sherpa Ventures, Synergy Ventures, Troy Capital
|
||||||
11/19/2014 | Series A | $7.7MM | $xx.xx | $25.68MM | Immortalana, Sherpa Ventures | |
Price per Share
$xx.xx
Shares Outstanding
8,399,256
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Immortalana, Sherpa Ventures
|